|
|
Previous Article | Table of Contents | Next Article 
Blood, 15 September 2001, Vol. 98, No. 6, pp. 1942-1948
PHAGOCYTES
Prostaglandin D2 is a potent chemoattractant for
human eosinophils that acts via a novel DP receptor
Guillaume Monneret,
Sylvie Gravel,
Michael Diamond,
Joshua Rokach, and
William S. Powell
From Meakins-Christie Laboratories, Department of
Medicine, McGill University, Montreal, QC, Canada, and Claude Pepper
Institute and Department of Chemistry, Florida Institute of Technology,
Melbourne, FL.
Prostaglandin D2 (PGD2) is released
following exposure of asthmatics to allergen and acts via the adenylyl
cyclase-coupled receptor for PGD2 (DP receptor).
In this study, it is reported that human eosinophils possess
this receptor, which would be expected to inhibit their activation. In
contrast, it was found that prostaglandin D2 is a potent
stimulator of eosinophil chemotaxis, actin polymerization, CD11b
expression, and L-selectin shedding. These responses are specific for
eosinophils, as neutrophils display little or no response to
prostaglandin D2. They were not due to interaction with
receptors for other prostanoids, as prostaglandins E2 and F2 , U46619 (a thromboxane A2 analogue), and
carbaprostacyclin (a prostacyclin analogue) displayed little or no
activity. Furthermore, they were not shared by the selective DP
receptor agonist BW245C and were not prevented by the selective DP
receptor antagonist BWA868C, indicating that they were not mediated by
DP receptors. In contrast, the prostaglandin D2 metabolite
13,14-dihydro-15-oxoprostaglandin D2 induced eosinophil
activation but did not stimulate DP receptor-mediated adenosine
3',5'-cyclic monophosphate (cAMP) formation. These results indicate
that in addition to the classic inhibitory DP1 receptor, eosinophils possess a second, novel DP2 receptor that is
associated with PGD2-induced cell activation. These 2 receptors appear to interact to regulate eosinophil responses to
PGD2, as blockade of DP1 receptor-mediated
cAMP production by BWA868C resulted in enhanced DP2
receptor-mediated stimulation of CD11b expression. The balance between
DP1 and DP2 receptors could determine the degree to which prostaglandin D2 can activate eosinophils
and may play a role in eosinophil recruitment in asthma.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. A. Boehme, E. P. Chen, K. Franz-Bacon, R. Sasik, L. J. Sprague, T. W. Ly, G. Hardiman, and K. B. Bacon
Antagonism of CRTH2 ameliorates chronic epicutaneous sensitization-induced inflammation by multiple mechanisms
Int. Immunol.,
January 1, 2009;
21(1):
1 - 17.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Schuligoi, M. Sedej, M. Waldhoer, A. Vukoja, E. M. Sturm, I. T. Lippe, B. A. Peskar, and A. Heinemann
Prostaglandin H2 induces the migration of human eosinophils through the chemoattractant receptor homologous molecule of Th2 cells, CRTH2
J. Leukoc. Biol.,
January 1, 2009;
85(1):
136 - 145.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Murata, M. I. Lin, K. Aritake, S. Matsumoto, S. Narumiya, H. Ozaki, Y. Urade, M. Hori, and W. C. Sessa
Role of prostaglandin D2 receptor DP as a suppressor of tumor hyperpermeability and angiogenesis in vivo
PNAS,
December 16, 2008;
105(50):
20009 - 20014.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. M. Sturm, P. Schratl, R. Schuligoi, V. Konya, G. J. Sturm, I. Th. Lippe, B. A. Peskar, and A. Heinemann
Prostaglandin E2 Inhibits Eosinophil Trafficking through E-Prostanoid 2 Receptors
J. Immunol.,
November 15, 2008;
181(10):
7273 - 7283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. W. Lukacs, A. A. Berlin, K. Franz-Bacon, R. Sasik, L. J. Sprague, T. W. Ly, G. Hardiman, S. A. Boehme, and K. B. Bacon
CRTH2 antagonism significantly ameliorates airway hyperreactivity and downregulates inflammation-induced genes in a mouse model of airway inflammation
Am J Physiol Lung Cell Mol Physiol,
November 1, 2008;
295(5):
L767 - L779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Tajima, T. Murata, K. Aritake, Y. Urade, H. Hirai, M. Nakamura, H. Ozaki, and M. Hori
Lipopolysaccharide Induces Macrophage Migration via Prostaglandin D2 and Prostaglandin E2
J. Pharmacol. Exp. Ther.,
August 1, 2008;
326(2):
493 - 501.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Nomiya, M. Okano, T. Fujiwara, M. Maeda, Y. Kimura, K. Kino, M. Yokoyama, H. Hirai, K. Nagata, T. Hara, et al.
CRTH2 Plays an Essential Role in the Pathophysiology of Cry j 1-Induced Pollinosis in Mice
J. Immunol.,
April 15, 2008;
180(8):
5680 - 5688.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shiraishi, K. Asano, K. Niimi, K. Fukunaga, M. Wakaki, J. Kagyo, T. Takihara, S. Ueda, T. Nakajima, T. Oguma, et al.
Cyclooxygenase-2/Prostaglandin D2/CRTH2 Pathway Mediates Double-Stranded RNA-Induced Enhancement of Allergic Airway Inflammation
J. Immunol.,
January 1, 2008;
180(1):
541 - 549.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Schratl, J. F. Royer, E. Kostenis, T. Ulven, E. M. Sturm, M. Waldhoer, G. Hoefler, R. Schuligoi, I. Th. Lippe, B. A. Peskar, et al.
The Role of the Prostaglandin D2 Receptor, DP, in Eosinophil Trafficking
J. Immunol.,
October 1, 2007;
179(7):
4792 - 4799.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Chen, B. Perussia, and K. S. Campbell
Prostaglandin D2 Suppresses Human NK Cell Function via Signaling through D Prostanoid Receptor
J. Immunol.,
September 1, 2007;
179(5):
2766 - 2773.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Parameswaran, K. Radford, A. Fanat, J. Stephen, C. Bonnans, B. D. Levy, L. J. Janssen, and P. G. Cox
Modulation of Human Airway Smooth Muscle Migration by Lipid Mediators and Th-2 Cytokines
Am. J. Respir. Cell Mol. Biol.,
August 1, 2007;
37(2):
240 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Hyo, R. Kawata, K. Kadoyama, N. Eguchi, T. Kubota, H. Takenaka, and Y. Urade
Expression of Prostaglandin D2 Synthase in Activated Eosinophils in Nasal Polyps
Arch Otolaryngol Head Neck Surg,
July 1, 2007;
133(7):
693 - 700.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sandig, J. E. Pease, and I. Sabroe
Contrary prostaglandins: the opposing roles of PGD2 and its metabolites in leukocyte function
J. Leukoc. Biol.,
February 1, 2007;
81(2):
372 - 382.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Cossette, S. E. Walsh, S. Kim, G.-J. Lee, J. A. Lawson, S. Bellone, J. Rokach, and W. S. Powell
Agonist and Antagonist Effects of 15R-Prostaglandin (PG) D2 and 11-Methylene-PGD2 on Human Eosinophils and Basophils
J. Pharmacol. Exp. Ther.,
January 1, 2007;
320(1):
173 - 179.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Satoh, R. Moroi, K. Aritake, Y. Urade, Y. Kanai, K. Sumi, H. Yokozeki, H. Hirai, K. Nagata, T. Hara, et al.
Prostaglandin D2 Plays an Essential Role in Chronic Allergic Inflammation of the Skin via CRTH2 Receptor
J. Immunol.,
August 15, 2006;
177(4):
2621 - 2629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Y. Park and J. W. Christman
Involvement of cyclooxygenase-2 and prostaglandins in the molecular pathogenesis of inflammatory lung diseases
Am J Physiol Lung Cell Mol Physiol,
May 1, 2006;
290(5):
L797 - L805.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Cheng, T.-J. Wu, K. K. Wu, C. Sturino, K. Metters, K. Gottesdiener, S. D. Wright, Z. Wang, G. O'Neill, E. Lai, et al.
Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans
PNAS,
April 25, 2006;
103(17):
6682 - 6687.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. A. Helliwell, J. A. Keelan, K. W. Marvin, L. Adams, M. C. Chang, A. Anand, T. A. Sato, S. O'Carroll, T. Chaiworapongsa, R. J. Romero, et al.
Gestational Age-Dependent Up-Regulation of Prostaglandin D Synthase (PGDS) and Production of PGDS-Derived Antiinflammatory Prostaglandins in Human Placenta
J. Clin. Endocrinol. Metab.,
February 1, 2006;
91(2):
597 - 606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. P. Mesquita-Santos, A. Vieira-de-Abreu, A. S. Calheiros, I. H. Figueiredo, H. C. Castro-Faria-Neto, P. F. Weller, P. T. Bozza, B. L. Diaz, and C. Bandeira-Melo
Cutting Edge: Prostaglandin D2 Enhances Leukotriene C4 Synthesis by Eosinophils during Allergic Inflammation: Synergistic In Vivo Role of Endogenous Eotaxin
J. Immunol.,
February 1, 2006;
176(3):
1326 - 1330.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Xue, S. L. Gyles, F. R. Wettey, L. Gazi, E. Townsend, M. G. Hunter, and R. Pettipher
Prostaglandin D2 Causes Preferential Induction of Proinflammatory Th2 Cytokine Production through an Action on Chemoattractant Receptor-Like Molecule Expressed on Th2 Cells
J. Immunol.,
November 15, 2005;
175(10):
6531 - 6536.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Chevalier, J. Stock, T. Fisher, M. Dupont, M. Fric, H. Fargeau, M. Leport, S. Soler, S. Fabien, M.-P. Pruniaux, et al.
Cutting Edge: Chemoattractant Receptor-Homologous Molecule Expressed on TH2 Cells Plays a Restricting Role on IL-5 Production and Eosinophil Recruitment
J. Immunol.,
August 15, 2005;
175(4):
2056 - 2060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F. G. Gervais, J.-P. Morello, C. Beaulieu, N. Sawyer, D. Denis, G. Greig, A. D. Malebranche, and G. P. O'Neill
Identification of a Potent and Selective Synthetic Agonist at the CRTH2 Receptor
Mol. Pharmacol.,
June 1, 2005;
67(6):
1834 - 1839.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Chung, S. M. Wildhirt, S. Wang, A. Koshal, and M. W. Radomski
Combined administration of nitric oxide gas and iloprost during cardiopulmonary bypass reduces platelet dysfunction: A pilot clinical study
J. Thorac. Cardiovasc. Surg.,
April 1, 2005;
129(4):
782 - 790.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. Almishri, C. Cossette, J. Rokach, J. G. Martin, Q. Hamid, and W. S. Powell
Effects of Prostaglandin D2, 15-Deoxy-{Delta}12,14-prostaglandin J2, and Selective DP1 and DP2 Receptor Agonists on Pulmonary Infiltration of Eosinophils in Brown Norway Rats
J. Pharmacol. Exp. Ther.,
April 1, 2005;
313(1):
64 - 69.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Shiraishi, K. Asano, T. Nakajima, T. Oguma, Y. Suzuki, T. Shiomi, K. Sayama, K. Niimi, M. Wakaki, J. Kagyo, et al.
Prostaglandin D2-Induced Eosinophilic Airway Inflammation Is Mediated by CRTH2 Receptor
J. Pharmacol. Exp. Ther.,
March 1, 2005;
312(3):
954 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Monneret, R. Boumiza, S. Gravel, C. Cossette, J. Bienvenu, J. Rokach, and W. S. Powell
Effects of Prostaglandin D2 and 5-Lipoxygenase Products on the Expression of CD203c and CD11b by Basophils
J. Pharmacol. Exp. Ther.,
February 1, 2005;
312(2):
627 - 634.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. B. Stamatiou, C.-C. Chan, G. Monneret, D. Ethier, J. Rokach, and W. S. Powell
5-Oxo-6,8,11,14-eicosatetraenoic Acid Stimulates the Release of the Eosinophil Survival Factor Granulocyte/Macrophage Colony-stimulating Factor from Monocytes
J. Biol. Chem.,
July 2, 2004;
279(27):
28159 - 28164.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Takeshita, T. Yamasaki, K. Nagao, H. Sugimoto, M. Shichijo, F. Gantner, and K. B. Bacon
CRTH2 is a prominent effector in contact hypersensitivity-induced neutrophil inflammation
Int. Immunol.,
July 1, 2004;
16(7):
947 - 959.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Bochenek, E Nizankowska, A Gielicz, M Swierczynska, and A Szczeklik
Plasma 9{alpha},11{beta}-PGF2, a PGD2 metabolite, as a sensitive marker of mast cell activation by allergen in bronchial asthma
Thorax,
June 1, 2004;
59(6):
459 - 464.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Angeli, D. Staumont, A.-S. Charbonnier, H. Hammad, P. Gosset, M. Pichavant, B. N. Lambrecht, M. Capron, D. Dombrowicz, and F. Trottein
Activation of the D Prostanoid Receptor 1 Regulates Immune and Skin Allergic Responses
J. Immunol.,
March 15, 2004;
172(6):
3822 - 3829.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Bohm, G. J. Sturm, I. Weiglhofer, H. Sandig, M. Shichijo, A. McNamee, J. E. Pease, M. Kollroser, B. A. Peskar, and A. Heinemann
11-Dehydro-thromboxane B2, a Stable Thromboxane Metabolite, Is a Full Agonist of Chemoattractant Receptor-homologous Molecule Expressed on TH2 Cells (CRTH2) in Human Eosinophils and Basophils
J. Biol. Chem.,
February 27, 2004;
279(9):
7663 - 7670.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.A. Keelan, J. Yang, R.J. Romero, T. Chaiworapongsa, K.W. Marvin, T.A. Sato, and M.D. Mitchell
Epithelial Cell-Derived Neutrophil-Activating Peptide-78 Is Present in Fetal Membranes and Amniotic Fluid at Increased Concentrations with Intra-amniotic Infection and Preterm Delivery
Biol Reprod,
January 1, 2004;
70(1):
253 - 259.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Shichijo, H. Sugimoto, K. Nagao, H. Inbe, J. A. Encinas, K. Takeshita, K. B. Bacon, and F. Gantner
Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells Activation in Vivo Increases Blood Leukocyte Counts and Its Blockade Abrogates 13,14-Dihydro-15-keto-prostaglandin D2-Induced Eosinophilia in Rats
J. Pharmacol. Exp. Ther.,
November 1, 2003;
307(2):
518 - 525.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. Noverr, J. R. Erb-Downward, and G. B. Huffnagle
Production of Eicosanoids and Other Oxylipins by Pathogenic Eukaryotic Microbes
Clin. Microbiol. Rev.,
July 1, 2003;
16(3):
517 - 533.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Sommer, R. Rickert, P. Fischer, H. Steinhart, R. D. Walter, and E. Liebau
A Dominant Role for Extracellular Glutathione S-Transferase from Onchocerca volvulus Is the Production of Prostaglandin D2
Infect. Immun.,
June 1, 2003;
71(6):
3603 - 3606.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Gosset, F. Bureau, V. Angeli, M. Pichavant, C. Faveeuw, A.-B. Tonnel, and F. Trottein
Prostaglandin D2 Affects the Maturation of Human Monocyte-Derived Dendritic Cells: Consequence on the Polarization of Naive Th Cells
J. Immunol.,
May 15, 2003;
170(10):
4943 - 4952.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Heinemann, R. Schuligoi, I. Sabroe, A. Hartnell, and B. A. Peskar
{Delta}12-Prostaglandin J2, a Plasma Metabolite of Prostaglandin D2, Causes Eosinophil Mobilization from the Bone Marrow and Primes Eosinophils for Chemotaxis
J. Immunol.,
May 1, 2003;
170(9):
4752 - 4758.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Sugimoto, M. Shichijo, T. Iino, Y. Manabe, A. Watanabe, M. Shimazaki, F. Gantner, and K. B. Bacon
An Orally Bioavailable Small Molecule Antagonist of CRTH2, Ramatroban (BAY u3405), Inhibits Prostaglandin D2-Induced Eosinophil Migration in Vitro
J. Pharmacol. Exp. Ther.,
April 1, 2003;
305(1):
347 - 352.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
G. Monneret, C. Cossette, S. Gravel, J. Rokach, and W. S. Powell
15R-Methyl-Prostaglandin D2 Is a Potent and Selective CRTH2/DP2 Receptor Agonist in Human Eosinophils
J. Pharmacol. Exp. Ther.,
January 1, 2003;
304(1):
349 - 355.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. G. Martin, M. Suzuki, K. Maghni, R. Pantano, D. Ramos-Barbon, D. Ihaku, F. Nantel, D. Denis, Q. Hamid, and W. S. Powell
The Immunomodulatory Actions of Prostaglandin E2 on Allergic Airway Responses in the Rat
J. Immunol.,
October 1, 2002;
169(7):
3963 - 3969.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Kohyama, T. A. Wyatt, X. Liu, F.-Q. Wen, T. Kobayashi, Q. Fang, H. J. Kim, and S. I. Rennard
PGD2 Modulates Fibroblast-Mediated Native Collagen Gel Contraction
Am. J. Respir. Cell Mol. Biol.,
September 1, 2002;
27(3):
375 - 381.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. E. L. Stubbs, P. Schratl, A. Hartnell, T. J. Williams, B. A. Peskar, A. Heinemann, and I. Sabroe
Indomethacin Causes Prostaglandin D2-like and Eotaxin-like Selective Responses in Eosinophils and Basophils
J. Biol. Chem.,
July 12, 2002;
277(29):
26012 - 26020.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Ward, I. Dransfield, J. Murray, S. N. Farrow, C. Haslett, and A. G. Rossi
Prostaglandin D2 and Its Metabolites Induce Caspase-Dependent Granulocyte Apoptosis That Is Mediated Via Inhibition of I{kappa}B{alpha} Degradation Using a Peroxisome Proliferator-Activated Receptor-{gamma}-Independent Mechanism
J. Immunol.,
June 15, 2002;
168(12):
6232 - 6243.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Monneret, H. Li, J. Vasilescu, J. Rokach, and W. S. Powell
15-Deoxy-{Delta}12,1412,14-prostaglandins D2 and J2 Are Potent Activators of Human Eosinophils
J. Immunol.,
April 1, 2002;
168(7):
3563 - 3569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Hirai, K. Tanaka, S. Takano, M. Ichimasa, M. Nakamura, and K. Nagata
Cutting Edge: Agonistic Effect of Indomethacin on a Prostaglandin D2 Receptor, CRTH2
J. Immunol.,
February 1, 2002;
168(3):
981 - 985.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. D. Funk
Prostaglandins and Leukotrienes: Advances in Eicosanoid Biology
Science,
November 30, 2001;
294(5548):
1871 - 1875.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|